Research study Program year 2023 Source: CMS Open Payments

Phase IIa study in patients with atopic dermatitis

Research payments

$1,145,618

362 payments

Through program year 2023, $1,145,618 in research payments was reported against Phase IIa study in patients with atopic dermatitis, across 362 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Canada Ltd.Ltee; Boehringer Ingelheim Pharma GmbH & Co.KG
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$12,885	2
2021	Research	$61,525	5
2020	Research	$337,403	102
2019	Research	$733,805	253

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $1,049,087 52 payments
Boehringer Ingelheim Canada Ltd.Ltee $68,339 301 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $28,191 9 payments

Who received the money Research payments · program years 2019–2023

Forward Clinical Trials Organisation paid for research $135,945 3 payments
Alliance For Multispecialty Research LLC Organisation paid for research $126,358 3 payments
Finlay Medical Research Corp Organisation paid for research $124,282 12 payments
Dermatology Treatment And Research Center Organisation paid for research $119,208 47 payments
Progressive Clinical Research PA Organisation paid for research $100,130 3 payments
University of South Florida Organisation paid for research $88,888 6 payments
Dermatological Association Of Texas Organisation paid for research $88,536 2 payments
Pharmaseek LLC Organisation paid for research $76,219 1 payment
The Indiana Clinical Trials Center Organisation paid for research $61,468 42 payments
Cognitive Clinical Trials LLC Organisation paid for research $57,322 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.